Previous 10 | Next 10 |
2024-02-21 07:30:02 ET JMP Securities analyst issues UNDERPERFORM recommendation for HALO on February 21, 2024 07:00AM ET. The previous analyst recommendation was Underperform. HALO was trading at $36 at issue of the analyst recommendation. The overall analyst consensus ...
2024-02-20 20:04:10 ET Halozyme Therapeutics, Inc. (HALO) Q4 2023 Earnings Conference Call February 20, 2024, 04:30 PM ET Company Participants Tram Bui - VP, IR and Corporate Communications Helen Torley - President and CEO Nicole LaBrosse - CFO Conference C...
2024-02-20 16:02:47 ET More on Halozyme Therapeutics Halozyme Therapeutics: A Reasonable Value In An Overvalued Market Halozyme Therapeutics Q4 2023 Earnings Preview EU okays Takeda's Hyqvia co-formulated with Halozyme's Enhanze Seeking Alpha’s Quant R...
HALOZYME REPORTS FOURTH QUARTER AND FULL YEAR 2023 FINANCIAL AND OPERATING RESULTS PR Newswire Reiterating 2024 Financial Guidance: Total Revenue of $915 -985 Million, Representing YOY Growth of 10-19%, Adjusted EBITDA of $535 -585 Million, Representing YOY Growth of 2...
Kajima Corporation ADR (KAJMY) is expected to report for quarter end 2023-12-31 FaZe Holdings Inc. (FAZE) is expected to report for Q4 2023 BrewBilt MFG Inc (BBRW) is expected to report for Q4 2023 Correlate Energy Corp. (CIPI) is expected to report for Q4 2023 Hyzon Motors Inc. (...
2024-02-16 17:20:16 ET More on Halozyme Therapeutics Halozyme Therapeutics: A Reasonable Value In An Overvalued Market EU okays Takeda's Hyqvia co-formulated with Halozyme's Enhanze Halozyme’s early 2023 results indicate a mixed performance Seeking Alp...
Halozyme To Report Fourth Quarter and Full Year 2023 Financial and Operating Results PR Newswire SAN DIEGO , Feb. 8, 2024 /PRNewswire/ -- Halozyme Therapeutics, Inc. (NASDAQ: HALO) ("Halozyme") today announced it will release its fourth quarter and full year 2023...
2024-01-30 16:40:26 ET More on Johnson & Johnson Johnson & Johnson: Positioned To Receive Benefits Of Heavy R&D Investments Johnson & Johnson: Balance Growth Between MedTech And Medicine, Initiate With A 'Buy' Johnson & Johnson 2023 Q4 - Results -...
2024-01-30 12:05:00 ET Summary Bernzott Capital Advisors is an independent money manager for institutional and private clients. We are 100% owned by employees and an employee-related individual. Global financial markets rallied in 4Q, with small cap stocks leading the way. Des...
2024-01-30 07:46:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
News, Short Squeeze, Breakout and More Instantly...
Halozyme Therapeutics Inc. Company Name:
HALO Stock Symbol:
NASDAQ Market:
Halozyme Therapeutics Inc. Website:
Halozyme to Report Second Quarter 2024 Financial and Operating Results PR Newswire SAN DIEGO , July 23, 2024 /PRNewswire/ -- Halozyme Therapeutics, Inc. (NASDAQ: HALO) ("Halozyme") today announced it will release its second quarter 2024 financial and operating re...
2024-07-22 03:26:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...